Exosomes released from M2 macrophages transfer miR‐221‐3p contributed to EOC progression through targeting CDKN1B
Authors:
Open Access
- 26 June 2020
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 9 (16) , 5976-5988
Abstract
In contrast to other solid tumors within the abdominal cavity, epithelial ovarian cancers (EOCs) tend to undergo peritoneal metastasis. Thus, the peritoneal immune microenvironment is crucial for EOC progression. Previous reports indicate that the main immune cells within the peritoneum are M2 macrophages, specifically tumor‐associated macrophages (TAMs). The communication between TAMs and tumor cells plays an important role in EOC development, and exosomes, acting as micro–message carriers, occupy an essential position in this process. Microarray analyses of exosomes revealed that miR‐221‐3p was enriched in M2 exosomes. Furthermore, miR‐221‐3p suppressed cyclin‐dependent kinase inhibitor 1B (CDKN1B) directly. Thus, miR‐221‐3p contributed to the proliferation and G1/S transition of EOC cells. Additionally, low levels of CDKN1B were associated with EOC progression and poor prognosis. These observations suggest that TAMs‐derived exosomal miR‐221‐3p acts as a regulator of EOC progression by targeting CDKN1B. The results of this study confirm that certain exosomal microRNAs may provide novel diagnostic biomarkers and therapeutic targets for EOC.Keywords
Funding Information
- National Natural Science Foundation of China (81602280)
This publication has 33 references indexed in Scilit:
- Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancerMolecular Cancer, 2014
- Somatic mutation of CDKN1B in small intestine neuroendocrine tumorsNature Genetics, 2013
- Interaction of monocytes/macrophages with ovarian cancer cells promotes angiogenesis in vitroCancer Science, 2013
- Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasivenessCarcinogenesis, 2011
- CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemiaHaematologica, 2011
- p27kip1: A New Multiple Endocrine Neoplasia Gene?Neuroendocrinology, 2010
- MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27Blood, 2010
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature Cell Biology, 2008
- MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinomaOncogene, 2008
- The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapyNature Reviews Cancer, 2008